Francesca Romana Spinelli

Pubblicazioni

Titolo Pubblicato in Anno
Clinical features of diabetes mellitus on rheumatoid arthritis. data from the cardiovascular obesity and rheumatic disease (CORDIS) Study group JOURNAL OF CLINICAL MEDICINE 2023
Janus kinase inhibitors: between prescription authorization and reimbursability REUMATISMO 2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib. SCIENTIFIC REPORTS 2023
Rheumatoid arthritis from easy to complex disease. from the "2022 GISEA international symposium" JOURNAL OF CLINICAL MEDICINE 2023
Janus kinase inhibitors: between prescription authorization and reimbursability REUMATISMO 2023
Exercise-induced modulation of Interferon-signature. a therapeutic route toward management of systemic lupus erythematosus AUTOIMMUNITY REVIEWS 2023
Telemedicine for rheumatological consultation. the new semeiotics for rheumatic examination CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile:. results from an observational multicentre rheumatoid arthritis cohort AUTOIMMUNITY REVIEWS 2023
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Correspondence on 'characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease. data from the COVID-19 global rheumatology alliance physician-reported registry' by gianfrancesco m et al. the impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients ANNALS OF THE RHEUMATIC DISEASES 2023
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus CELLS 2022
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine ARTHRITIS RESEARCH & THERAPY 2022
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2022
Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients FRONTIERS IN PHARMACOLOGY 2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study BIOMOLECULES 2022
Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia FRONTIERS IN IMMUNOLOGY 2022
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors? PLOS ONE 2022
Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren’s Syndrome by 99mTc-Interleukin-2: Diagnostic and Therapeutic Implications JOURNAL OF CLINICAL MEDICINE 2022
Baricitinib therapy response in rheumatoid arthritis patients associates to STAT1 phosphorylation in monocytes FRONTIERS IN IMMUNOLOGY 2022
Fever in systemic lupus erythematosus: associated clinical features and genetic factors CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma